- Home
- KLRS vs JG Comparison
KLRS vs JG Comparison
Compare KLRS & JG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLRS
- JG
- Stock Information
- Founded
- KLRS 2019
- JG 2012
- Country
- KLRS United States
- JG China
- Employees
- KLRS N/A
- JG N/A
- Industry
- KLRS Biotechnology: Biological Products (No Diagnostic Substances)
- JG Computer Software: Programming Data Processing
- Sector
- KLRS Health Care
- JG Technology
- Exchange
- KLRS Nasdaq
- JG Nasdaq
- Market Cap
- KLRS 46.0M
- JG 48.4M
- IPO Year
- KLRS N/A
- JG 2018
- Fundamental
- Price
- KLRS $6.46
- JG $8.45
- Analyst Decision
- KLRS Strong Buy
- JG
- Analyst Count
- KLRS 2
- JG 0
- Target Price
- KLRS $23.00
- JG N/A
- AVG Volume (30 Days)
- KLRS 232.2K
- JG 10.0K
- Earning Date
- KLRS 11-15-2025
- JG 11-13-2025
- Dividend Yield
- KLRS N/A
- JG N/A
- EPS Growth
- KLRS N/A
- JG N/A
- EPS
- KLRS N/A
- JG N/A
- Revenue
- KLRS N/A
- JG $48,999,972.00
- Revenue This Year
- KLRS N/A
- JG $10.90
- Revenue Next Year
- KLRS N/A
- JG N/A
- P/E Ratio
- KLRS N/A
- JG N/A
- Revenue Growth
- KLRS N/A
- JG 18.82
- 52 Week Low
- KLRS $2.14
- JG $4.25
- 52 Week High
- KLRS $24.15
- JG $20.94
- Technical
- Relative Strength Index (RSI)
- KLRS 59.57
- JG 40.20
- Support Level
- KLRS $6.50
- JG $8.02
- Resistance Level
- KLRS $8.80
- JG $8.79
- Average True Range (ATR)
- KLRS 0.95
- JG 0.39
- MACD
- KLRS 0.09
- JG 0.02
- Stochastic Oscillator
- KLRS 51.28
- JG 30.26
About KLRS Kalaris Therapeutics Inc. Common Stock
Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor (VEGF) drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.
About JG Aurora Mobile Limited
Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.